Skip to main content
. 2023 Dec 1;22:210. doi: 10.1186/s12944-023-01981-2

Table 2.

Description of study participants

Characteristic Fifths of TyG-BMI index (N = 114,957)
Q1 Q2 Q3 Q4 Q5
22,991 22,991 22,993 22,991 22,991
Age, years, mean (SE) 50.9 (0.1) 52.5 (0.1) 53.6 (0.1) 54.4 (0.1) 54.4 (0.1)
BMI, kg/m2, mean (SE) 20.5 (0.0) 22.5 (0.0) 23.7 (0.0) 25.1 (0.0) 27.7 (0.0)
Male, n (%) 4,207 (18.3) 5,104 (22.2) 5,909 (25.7) 6,644 (28.9) 6,782 (29.5)
Elementary education, n (%) 2,028 (8.8) 2,656 (11.6) 3,312 (14.4) 4,215 (18.3) 5,053 (22.0)
Income, < 1000USD, n (%) 1,748 (7.6) 1,859 (8.1) 2,154 (9.4) 2,537 (11.0) 2,913 (12.7)
Single/others, n (%) 2,527 (11.0) 2,180 (9.5) 2,274 (9.9) 2,354 (10.2) 2,726 (11.9)
Rural residents, n (%) 7,195 (31.3) 7,146 (31.1) 7,115 (30.9) 7,379 (32.1) 7,764 (33.8)
Current smokers, n (%) 3,196 (13.9) 3,487 (15.2) 3,555 (15.5) 3,612 (15.7) 3,514 (15.3)
Current drinkers, n (%) 10,587 (46.1) 10,534 (45.8) 10,503 (45.7) 10,028 (43.6) 10,101 (43.9)
Regular exercise, n (%) 7,984 (34.7) 8,472 (36.9) 8,727 (38.0) 8,433 (36.7) 7,634 (33.2)
Elevated hs-CRP, n (%) 1,071 (4.7) 1,176 (5.1) 1,418 (6.2) 1,621 (7.1) 2,454 (10.7)
History of Cancer, n (%) 854 (3.7) 731 (3.2) 766 (3.3) 752 (3.3) 712 (3.1)
History of CVD, n (%) 328 (1.4) 443 (1.9) 555 (2.4) 651 (2.8) 750 (3.3)
Disease score, ≥ 1, n (%) 1,372 (6.0) 1,691 (7.4) 2,005 (8.7) 2,134 (9.3) 2,495 (10.9)
TyG, median (IQR) 7.9 (7.6–8.2) 8.3 (7.9–8.5) 8.5 (8.2–8.8) 8.7 (8.4-9.0) 9.1 (8.7–9.4)
TyG-BMI, median (IQR) 164 (164 − 155) 184 (178–191) 199 (193–208) 218 (210–224) 247 (236–261)
TyG-WC, median (IQR) 572 (533–620) 634 (593–685) 678 (636–731) 727 (684–777) 808 (755–865)
METS-IR, median (IQR) 27.0 (25.9–29.4) 31.3 (29.7–33.2) 34.0 (32.4–36.0) 37.1 (35.4–39.2) 42.6 (40.0-45.6)
VAI, median (IQR) 1.8 (1.3–2.3) 2.2 (1.6–2.9) 2.6 (1.9–3.4) 3.0 (2.3–3.9) 3.8 (2.8–5.2)
LAP, median (IQR) 8.5 (5.6–12.3) 15.9 (11.7–21.5) 23.2 (17.4–31.2) 33.4 (25.2–44.6) 54.5 (39.9–77.2)

SE, standard error; IQR, interquartile range; BMI, body mass index; TyG, triglyceride-glucose index; WC, waist circumference; VAI, visceral adiposity index; LAP, lipid accumulation product; METS-IR, metabolic score for insulin resistance; CVD, cardiovascular disease; hs-CRP, high sensitivity C-reactive protein